David Medina is a recently graduated Ph.D. in Chemical Engineering with a focus on Nanomedicine and Green Nanotechnology to treat and manage antibiotic-resistant bacterial infections and chemotherapy-resistant tumors. He is the co-founder at two biomedical startups (SynCell Biotechnology and Novaurum Biosciences) and a CleanTech spinout from Northeastern University (Nanolyx Inc), as well as the CFO of a national non-profit of Spanish scientists in the US.